1.

Record Nr.

UNINA9910450162003321

Titolo

Drug design [[electronic resource] ] : cutting edge approaches / / edited by Darren R. Flower

Pubbl/distr/stampa

Cambridge, U.K., : Royal Society of Chemistry, c2002

ISBN

1-84755-070-3

1-60119-027-1

Descrizione fisica

1 online resource (204 p.)

Collana

Special publication ; ; no. 279

Altri autori (Persone)

FlowerDarren R

Disciplina

615.19

Soggetti

Drugs - Design

Drugs - Design - Mathematical models

Artificial intelligence - Medical applications

Drugs - Research - Methodology

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

"Proceedings of the meeting on Cutting Edge Approaches to Drug Design held on 13 March 2001 at the Scientific Societies Lecture Theatre, London, UK"--T.p. verso.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

CONTENTS; Molecular Informatics: Sharpening Drug Design's Cutting Edge; High-Throughput X-Ray Crystallography for Drug Discovery; Trawling the Genome for G Protein-coupled Receptors: the Importance of Integrating Bioinformatic Approaches; Virtual Screening of Virtual Libraries - an Efficient Strategy for LeadGeneration; Virtual Techniques for Lead Optimisation; The Impact of Physical Organic Chemistry on the Control of Drug-likeProperties; Mutagenesis and Modelling Highlight the Critical Nature of theTM2-loop-TM3 Region of Biogenic Amine GPCRS; Computational Vaccine Design; Subject Index

Sommario/riassunto

Pharmaceutical research draws on increasingly complex techniques to solve the challenges of drug design. Bringing together a number of the latest informatics techniques, this book looks at modelling and bioinformatic strategies; structural genomics and X-ray crystallography; virtual screening; lead optimisation; ADME profiling and vaccine design. A number of relevant case studies, focussing on techniques that have demonstrated their use, will concentrate on G-



protein coupled receptors as potential disease targets.Providing details of state-of-the-art research, Drug Design: Cutting Edge Approac